Mark Chaballa
About Mark Chaballa
Mark Chaballa is an Orencia Medical Scientist at Bristol Myers Squibb in Princeton, New Jersey, with extensive experience in transplant surgery and clinical research.
Current Role at Bristol Myers Squibb
Mark Chaballa currently works as an Orencia Medical Scientist at Bristol Myers Squibb in Princeton, New Jersey, United States. He began this role in April 2020 and contributes to the company's efforts in biopharmaceutical research and innovation.
Past Experience at Thomas Jefferson University Hospitals
Mark Chaballa has extensive experience working at Thomas Jefferson University Hospitals in Philadelphia, PA. He served in multiple roles, including Vice Chair of the Institutional Review Board for 11 years from 2009 to 2020, Adjunct Assistant Professor for 8 years from 2012 to 2020, and Clinical Pharmacy Specialist in Transplant Surgery for 23 years from 1997 to 2020.
Specialty Residency at University of Tennessee Bowld Hospital
Mark Chaballa completed a specialty residency in Transplantation and Immunology at the University of Tennessee Bowld Hospital in Memphis, TN. He held this role for one year from 1996 to 1997, focusing on advanced training in these medical fields.
Educational Background in Pharmacy
Mark Chaballa studied at the University of the Sciences in Philadelphia, where he achieved both a Doctor of Pharmacy (PharmD) and a Bachelor of Pharmacy (BPharm). His studies spanned six years from 1990 to 1996, providing a strong foundation in pharmacy and clinical practices.
Experience in Transplant Surgery
With 23 years of experience as a Clinical Pharmacy Specialist in Transplant Surgery at Thomas Jefferson University Hospitals, Mark Chaballa has extensive expertise in this specialized medical field. His role involved supporting transplant procedures and patient care.